Lumoxiti
- Licence status
- Withdrawn: 23/07/2021
- Active substances
- Moxetumomab pasudotox
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/20/1522/001-002
- Licence holder
- AstraZeneca AB
Licence information
- ATC code
- L01XC Monoclonal antibodies, L01XC34 moxetumomab pasudotox
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 08/02/2021